TITLE

Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis

AUTHOR(S)
Rigamonti, C.; Shand, L. M.; Feudjo, M.; Bunn, C. C.; Black, C. M.; Denton, C. P.; Burroughs, A. K.
PUB. DATE
March 2006
SOURCE
Gut;Mar2006, Vol. 55 Issue 3, p388
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Backgrounds and aims: To evaluate the prognosis of primary biliary cirrhosis (PBC) together with systemic sclerosis (SSc) as this is unknown. Methods and results: A PBC database of 580 patients identified 43 with PBC and SSc: two patients with PBC alone were matched to each PBC-SSc patient for serum bilirubin concentration at the initial visit. Forty (93%) patients had limited cutaneous SSc. At diagnosis of PBC, median values were: 49.7 years, bilirubin 17 μmol/l, and albumin 40.5 g/l. Liver diagnosis occurred a median 4.9 years after SSc in 24 (56%) patients. In matched patients, median values at diagnosis were: 53.2 years, bilirubin 12 μmol/l, and albumin 41 g/l. Median follow up was similar: 3.16 years (PBC-SSc) and 4.8 years (PBC alone). The risk of transplantation or death from diagnosis, adjusting for sex, age, log bilirubin, and alkaline phosphatase was significantly lower in PBC-SSc (hazard ratio 0.116, p =0.01) due to less transplantation (hazard ratio 0.068, p = 0.006). The rate of bilirubin increase was less in PBC-SSc (p = 0.04). Overall survival was similar (hazard ratio 1.11, p = 0.948); there were nine deaths (21%) in PBC-SSc (six SSc related and two liver related) and nine (11%) in PBC alone (six liver related). Conclusions: Liver disease has a slower progression in PBC-SSc compared with matched patients with PBC alone.
ACCESSION #
20098094

 

Related Articles

  • Nailfold Capillaroscopy in Primary Biliary Cirrhosis: a Useful Tool for the Early Diagnosis of Scleroderma. Tovoli, Francesco; Granito, Alessandro; Giampaolo, Luca; Frisoni, Magda; Volta, Umberto; Fusconi, Marco; Masi, Chiara; Lenzi, Marco // Journal of Gastrointestinal & Liver Diseases;Mar2014, Vol. 23 Issue 1, p39 

    Background & Aim. Primary biliary cirrhosis (PBC) is frequently associated with other autoimmune diseases, including systemic sclerosis (SSc). In the last years many efforts have been dedicated to the research of widely accepted criteria for the early diagnosis of SSc. Since studies on the...

  • Elevated Serum IgG4 Concentration in Patients with Primary Sclerosing Cholangitis. Mendes, Flavia D.; Jorgensen, Roberta; Keach, Jill; Katzmann, Jerry A.; Smyrk, Thomas; Donlinger, Jessica; Chari, Suresh; Lindor, Keith D. // American Journal of Gastroenterology;Sep2006, Vol. 101 Issue 9, p2070 

    OBJECTIVES: Biliary strictures, similar to primary sclerosing cholangitis (PSC), have been reported in patients with autoimmune pancreatitis, which is characterized by elevated serum IgG4 levels and responsiveness to corticosteroids. We sought to determine the frequency of elevated IgG4 in...

  • Primary Biliary Cirrhosis Associated with Systemic Sclerosis: Diagnostic and Clinical Challenges. Rigamonti, Cristina; Bogdanos, Dimitrios P.; Mytilinaiou, Maria G.; Smyk, Daniel S.; Rigopoulou, Eirini I.; Burroughs, Andrew K. // International Journal of Rheumatology;2011, Vol. 2011, p1 

    Patients with primary biliary cirrhosis (PBC) often have concurrent limited systemic sclerosis (SSc). Conversely, up to onefourth of SSc patients are positive for PBC-specific antimitochondrial antibodies (AMA). The mechanisms responsible for the co-occurrence of these diseases are largely...

  • Hepatic Osteodystrophy Is Common in Patients with Noncholestatic Liver Disease. Choudhary, N.; Tomar, M.; Chawla, Y.; Bhadada, S.; Khandelwal, N.; Dhiman, R.; Duseja, A.; Bhansali, A. // Digestive Diseases & Sciences;Nov2011, Vol. 56 Issue 11, p3323 

    Background: Patients with cirrhosis are more prone to develop metabolic bone disease. Scanty literature data are available on osteodystrophy in patients from India with noncholestatic liver diseases. Methods: Patients diagnosed with cirrhosis were prospectively evaluated for bone mineral density...

  • Predicting outcome in primary biliary cirrhosis. Lammers, Willem J.; Kowdley, Kris V.; van Buuren, Henk R. // Annals of Hepatology: Official Journal of the Mexican Associatio;Jul/Aug2014, Vol. 13 Issue 4, p316 

    Primary biliary cirrhosis (PBC) is a slowly progressive autoimmune liver disease that may ultimately result in liver failure and premature death. Predicting outcome is of key importance in clinical management and an essential requirement for patients counselling and timing of diagnostic and...

  • Clinical: Case Study - Investigating raised LFTs.  // GP: General Practitioner;9/5/2012, p31 

    The article reports on a medical case involving a 74-year-old woman who had her Liver Function Tests (LFTs) checked routinely as part of annual hypertension screen. Her LFTs revealed raised gamma-glutamyl transpeptidase (GGT) and alkaline phosphatase.(ALP) of 92 and 184 units/L respectively...

  • Bezafibrate treatment: a new medical approach for PBC patients? Kanda, Tatsuo; Yokosuka, Osamu; Imazeki, Fumio; Saisho, Hiromitsu // Journal of Gastroenterology;2003, Vol. 38 Issue 6, p573 

    Background. A new medical approach to primary biliary cirrhosis (PBC) has been desired. We investigated the feasibility of using combination ursodeoxycholic acid (UDCA)-bezafibrate therapy in patients with PBC non-responsive to UDCA monotherapy. Methods. During a 6-month period, 22 PBC patients...

  • Prognostic Value of Hepatocyte Proliferative Activity After Transjugular Intrahepatic Portosystemic Shunt. Delhaye, Myriam; Le Moine, Olivier; Degraef, Chantal; Devière, Jacques; Galand, Paul // American Journal of Gastroenterology;Jun2001, Vol. 96 Issue 6, p1866 

    OBJECTIVES: Previous data indicated that the proliferating cell nuclear antigen-labeling index (PCNA-LI) reflects the liver functional reserve in human liver cirrhosis. The aim of the study was to evaluate the hepatocyte proliferative activity as a marker for the outcome of patients after...

  • Application of a biochemical and clinical model to predict individual survival in patients with end-stage liver disease. Gomez, Eduardo Vilar; Bertot, Luis Calzadilla; Oramas, Bienvenido Gra; Soler, Enrique Arus; Navarro, Raimundo Llanio; Elias, Javier Diaz; Jiménez, Oscar Villa; Vazquez, Maria del Rosario Abreu; Akbar, Sheikh Mohammad Fazle // World Journal of Gastroenterology;6/14/2009, Vol. 15 Issue 22, p2768 

    AIM: To investigate the capability of a biochemical and clinical model, BioCliM, in predicting the survival of cirrhotic patients. METHODS: We prospectively evaluated the survival of 172 cirrhotic patients. The model was constructed using clinical (ascites, encephalopathy and variceal bleeding)...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics